Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Hu, Zhe Yuan ^a   Yuan, Sheng Xian ^b   Yang, Yuan ^b   Zhou, Wei Ping ^b   Jiang, Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Metastasis; Nucleus shuttling; PLAG1; Prognosis; Tumor growth

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 2; PLEOMORPHIC ADENOMA GENE 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; KPNA2 PROTEIN, HUMAN; PLAG1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR IMPORT; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL; RISK FACTOR; STAINING; CELL MOTION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL; TUMOR CELL LINE;

ALPHA KARYOPHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 84906567126     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0061-1     Document Type: Article

References (27)

1. Cancer statistics, 2012. R Siegel, D Naishadham, A Jemal, CA Cancer J Clin 2012 62 1 10 29 10.3322/caac.20138 22237781
2. Hepatocellular carcinoma. A Forner, JM Llovet, J Bruix, Lancet 2012 379 9822 1245 1255 10.1016/S0140-6736(11)61347-0 22353262
3. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. MQ Fan, CB Huang, Y Gu, Y Xiao, JX Sheng, L Zhong, J Exp Clin Cancer Res 2013 32 1 21 10.1186/1756-9966-32-21 23594563
4. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-kappaB pathways induced by paracrine cytokines. YH Wang, YY Dong, WM Wang, XY Xie, ZM Wang, RX Chen, J Chen, DM Gao, JF Cui, ZG Ren, J Exp Clin Cancer Res 2013 32 1 51 10.1186/1756-9966-32-51 23941552
5. Nuclear transport and cancer: from mechanism to intervention. TR Kau, JC Way, PA Silver, Nat Rev Cancer 2004 4 2 106 117 10.1038/nrc1274 14732865
6. Karyopherin flexibility in nucleocytoplasmic transport. E Conti, CW Muller, M Stewart, Curr Opin Struct Biol 2006 16 2 237 244 10.1016/j.sbi.2006.03.010 16567089
7. The functional role of the novel biomarker karyopherin alpha 2 (KPNA2) in cancer. A Christiansen, L Dyrskjot, Cancer Lett 2013 331 1 18 23 10.1016/j.canlet.2012.12.013 23268335
8. Nuclear karyopherin-alpha2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. B Altan, T Yokobori, E Mochiki, T Ohno, K Ogata, A Ogawa, M Yanai, T Kobayashi, B Luvsandagva, T Asao, H Kuwano, Carcinogenesis 2013 34 10 2314 21 10.1093/carcin/bgt214 23749771
9. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. A Mortezavi, T Hermanns, HH Seifert, MK Baumgartner, M Provenzano, T Sulser, M Burger, M Montani, K Ikenberg, F Hofstadter, A Hartmann, R Jaggi, H Moch, G Kristiansen, PJ Wild, Clin Cancer Res 2011 17 5 1111 1121 10.1158/1078-0432.CCR-10-0081 21220479
10. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. J Jiang, D Sliva, Int J Oncol 2010 37 6 1529 1536 21042722
11. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma. C Li, L Ji, ZY Ding, QD Zhang, GR Huang, Tumour Biol 2013 34 2 1021 1026 10.1007/s13277-012-0641-7 23283818
12. Importin-alpha1 as a novel prognostic target for hepatocellular carcinoma. K Yoshitake, S Tanaka, K Mogushi, A Aihara, A Murakata, S Matsumura, Y Mitsunori, M Yasen, D Ban, N Noguchi, T Irie, A Kudo, N Nakamura, H Tanaka, S Arii, Ann Surg Oncol 2011 18 7 2093 2103 10.1245/s10434-011-1569-7 21286940
13. Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. CV Braem, K Kas, E Meyen, M Debiec-Rychter, WJ Van De Ven, ML Voz, J Biol Chem 2002 277 22 19673 19678 10.1074/jbc.M112112200 11882654
14. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. A Zatkova, JM Rouillard, W Hartmann, BJ Lamb, R Kuick, M Eckart, D von Schweinitz, A Koch, C Fonatsch, T Pietsch, SM Hanash, K Wimmer, Genes Chromosomes Cancer 2004 39 2 126 137 10.1002/gcc.10307 14695992
15. PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study. A Matsuyama, M Hisaoka, H Hashimoto, Virchows Arch 2011 459 5 539 545 10.1007/s00428-011-1149-z 21927843
16. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). F Van Dyck, J Declercq, CV Braem, WJ Van de Ven, Int J Oncol 2007 30 4 765 774 17332914
17. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. L Hu, SH Lau, CH Tzang, JM Wen, W Wang, D Xie, M Huang, Y Wang, MC Wu, JF Huang, WF Zeng, JS Sham, M Yang, XY Guan, Oncogene 2004 23 1 298 302 14647434
18. Posthepatectomy HBV Reactivation in Hepatitis B-Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels. G Huang, EC Lai, WY Lau, WP Zhou, F Shen, ZY Pan, SY Fu, MC Wu, Ann Surg 2013 257 3 490 505 10.1097/SLA.0b013e318262b218 22868358
19. Molecular signatures and prognosis of hepatocellular carcinoma. Y Hoshida, Minerva Gastroenterol Dietol 2011 57 3 311 322 21769080
20. Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells. YW Chen, V Boyartchuk, BC Lewis, Neoplasia 2009 11 9 835 845 19724677
21. Overexpression of Kpnbeta1 and Kpnalpha2 importin proteins in cancer derives from deregulated E2F activity. PJ van der Watt, E Ngarande, VD Leaner, PLoS One 2011 6 11 27723 10.1371/journal.pone.0027723 22125623
22. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. L Huang, HY Wang, JD Li, JH Wang, Y Zhou, RZ Luo, JP Yun, Y Zhang, WH Jia, M Zheng, Cell Death Dis 2013 4 745 10.1038/cddis.2013.256 23907459
23. Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. E Krawczyk, JA Hanover, R Schlegel, FA Suprynowicz, Biochem Biophys Res Commun 2008 371 4 684 688 10.1016/j.bbrc.2008.04.122 18455505
24. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland. A Matsuyama, M Hisaoka, H Hashimoto, Pathol Int 2012 62 1 1 7 10.1111/j.1440-1827.2011.02740.x 22192798
25. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. M Patz, CP Pallasch, CM Wendtner, Leuk Lymphoma 2010 51 8 1379 1381 10.3109/10428194.2010.496016 20687796
26. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. J von Frowein, P Pagel, R Kappler, D von Schweinitz, A Roscher, I Schmid, Hepatology 2011 53 3 833 842 10.1002/hep.24125
27. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. V Tovar, C Alsinet, A Villanueva, Y Hoshida, DY Chiang, M Sole, S Thung, S Moyano, S Toffanin, B Minguez, L Cabellos, J Peix, M Schwartz, V Mazzaferro, J Bruix, JM Llovet, J Hepatol 2010 52 4 550 559 10.1016/j.jhep.2010.01.015 20206398